- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Small bowel angioectasia as a marker of frailty and poor prognosis ; volume:08 ; number:07 ; year:2020 ; pages:E953-E958
Endoscopy International Open ; 08, Heft 07 (2020), E953-E958
- Contributor
-
Robertson, Alexander R.
Koulaouzidis, Anastasios
Brindle, William M.
Robertson, Andrew J.
Plevris, John N.
- DOI
-
10.1055/a-1180-8319
- URN
-
urn:nbn:de:101:1-2020090412462772740120
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Robertson, Alexander R.
- Koulaouzidis, Anastasios
- Brindle, William M.
- Robertson, Andrew J.
- Plevris, John N.
Other Objects (12)
Podocalyxin is a marker of poor prognosis in colorectal cancer
Hematologic markers of distant metastases and poor prognosis in gynecological cancers
Circulating tumor cells: a valuable marker of poor prognosis for advanced nasopharyngeal carcinoma
Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer
Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer
DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma Patients
Krüppel-Like Factor 7 is a Marker of Aggressive Gastric Cancer and Poor Prognosis
Evaluating frailty assessment tools and biological frailty markers in C57BL/6 female mice
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer
Circulating tumor cells as marker of poor prognosis in metastatic lung cancer: a pilot study
EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis
Podocalyxin is a marker of poor prognosis in colorectal cancer
Hematologic markers of distant metastases and poor prognosis in gynecological cancers
Circulating tumor cells: a valuable marker of poor prognosis for advanced nasopharyngeal carcinoma
Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer
Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer
DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma Patients
Krüppel-Like Factor 7 is a Marker of Aggressive Gastric Cancer and Poor Prognosis
Evaluating frailty assessment tools and biological frailty markers in C57BL/6 female mice
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer
Circulating tumor cells as marker of poor prognosis in metastatic lung cancer: a pilot study
EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis
Podocalyxin is a marker of poor prognosis in colorectal cancer
Hematologic markers of distant metastases and poor prognosis in gynecological cancers
Circulating tumor cells: a valuable marker of poor prognosis for advanced nasopharyngeal carcinoma
Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer
Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer
DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma Patients
Krüppel-Like Factor 7 is a Marker of Aggressive Gastric Cancer and Poor Prognosis
Evaluating frailty assessment tools and biological frailty markers in C57BL/6 female mice
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer
Circulating tumor cells as marker of poor prognosis in metastatic lung cancer: a pilot study